Current Pharmaceutical Design
Volume 26, 46 Issues, 2020
ISSN: 1873-4286 (Online)
ISSN: 1381-6128 (Print)
This journal supports open access
ISSN: 1873-4286 (Online)
ISSN: 1381-6128 (Print)
This journal supports open access
Ranking and Category
-
148th of 267 in
Pharmacology & Pharmacy
Contents
Current Pharmaceutical Design, Volume 10 - Number 25
Preface [Hot Topic: Novel Immunomodulatory Effects of Macrolides in Inflammatory Lung Disease (Executive Editors: F. Martinez and T.J. Standiford)]
, 10(25): iFernando Martinez and Theodore J. Standiford
DOI: 10.2174/1381612043383395
The Macrolide Antibiotics: A Pharmacokinetic and Pharmacodynamic Overview
, 10(25): 3045 - 3053R. Jain and L. H. Danziger
DOI: 10.2174/1381612043383322
Regulatory Effects of Macrolides on Bacterial Virulence: Potential Role as Quorum-Sensing Inhibitors
, 10(25): 3055 - 3065Kazuhiro Tateda, Theodore J. Standiford, Jean Claude Pechere and Keizo Yamaguchi
DOI: 10.2174/1381612043383377
Cellular and Molecular Effects of Macrolides on Leukocyte Function
, 10(25): 3067 - 3080Marie-Therese Labro
DOI: 10.2174/1381612043383403
Immunomodulatory Effects of Macrolides in the Lung: Lessons from In- Vitro and In-Vivo Models
, 10(25): 3081 - 3093Wan C. Tsai and Theodore J. Standiford
DOI: 10.2174/1381612043383430
Clinical Implications of Macrolide Therapy in Chronic Sinopulmonary Diseases
, 10(25): 3095 - 3110Fernando J. Martinez and Richard H. Simon
DOI: 10.2174/1381612043383304
Rationale for the Development of Cholinesterase Inhibitors as Anti- Alzheimer Agents
, 10(25): 3111 - 3119D. K. Lahiri, J. T. Rogers, N. H. Greig and K. Sambamurti
DOI: 10.2174/1381612043383331
An Overview of the Current and Novel Drugs for Alzheimers Disease with Particular Reference to Anti-Cholinesterase Compounds
, 10(25): 3121 - 3130Marcela Colombres, Juan Paulo Sagal and Nibaldo C. Inestrosa
DOI: 10.2174/1381612043383359
Molecular Modelling Approaches to the Design of Acetylcholinesterase Inhibitors: New Challenges for the Treatment of Alzheimers Disease
, 10(25): 3131 - 3140J. Munoz-Muriedas, J. M. Lopez, Modesto Orozco and F. Javier Luque
DOI: 10.2174/1381612043383386
Development of Bivalent Acetylcholinesterase Inhibitors as Potential Therapeutic Drugs for Alzheimers Disease
, 10(25): 3141 - 3156Da-Ming Du and Paul R. Carlier
DOI: 10.2174/1381612043383412
Acetylcholinesterase Inhibitors as a Starting Point Towards Improved Alzheimers Disease Therapeutics
, 10(25): 3157 - 3166Maurizio Recanatini and Piero Valenti
DOI: 10.2174/1381612043383313
Recent Approaches to Novel Anti-Alzheimer Therapy
, 10(25): 3167 - 3175Carreiras M. C. and Marco J. L.
DOI: 10.2174/1381612043383421
New Classes of AChE Inhibitors with Additional Pharmacological Effects of Interest for the Treatment of Alzheimers Disease
, 10(25): 3177 - 3184M. Villarroya, A. G. García and J. L. Marco
DOI: 10.2174/1381612043383368
   |
Editor-in-Chief
William A. Banks
(29546 citations)
Seattle VA Puget Sound Health Care System
Room 810C, Building 1
1660 S. Columbian Way
Seattle, WA 98108
USA
Biography
View Full Editorial Board
(29546 citations)
Seattle VA Puget Sound Health Care System
Room 810C, Building 1
1660 S. Columbian Way
Seattle, WA 98108
USA
Biography
Biography of William A. Banks
Dr. Banks obtained his MD from the University of Missouri- Columbia and did clinical and research training at the Veterans Affairs Medical Center – New Orleans and Tulane University. He is currently Associate Chief of Staff –Research and Development at the Puget Sound VA and Professor of Medicine at University of Washington School of Medicine. His main interest is in blood-brain barrier function. He has published over 450 non-abstract articles, and over 20,000 citations according to Web of Science with an H-index fo 81.
About the Journal
For Authors
For Librarians & Readers
Quick Links
Journal History
Current Pharmaceutical Design was introduced in 1995 with the assistance of Dr. William A. Banks, who is the current Editor-in-Chief serving since 1995.
Scopus CiteScore Metrics: 2.32
Advertisement
Webmaster Contact: info@benthamscience.net